iHealth COVID-19 Antigen Rapid Test, FDA EUA Authorized At-home Self Test [2 tests/pack]

iHealth® COVID-19 Antigen Rapid Test, FDA EUA Authorized OTC At-home Self Test

Results in 15 Minutes with Non-invasive Nasal Swab, Easy to Use & No Discomfort. 

Best for children, the iHealth COVID-19 Antigen Rapid Test offers testing for those as young as two in your household.

Indication:  Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2.  

Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for emergency use of the iHealth COVID-19 Antigen Rapid Test.  FDA (EUA) Number: EUA210470.

KEY FEATURES

FDA AUTHORIZED 15 MINS SELF-TEST
The test is a 15-minute self-test to detect nucleocapsid protein antigen from SARS-CoV-2. The test can be completed in the comfort of your own home without the need to ship your sample to a lab.

EASY TO USE ZERO DISCOMFORT
Test can be done by inserting only 1/2 to 3/4 inch with a simple non-invasive nasal swab, easy to use, and zero discomfort. Step by step instructional videos are available in our app for easy following. (Installation of app is optional).

FOR AGES 2 AND ABOVE
The self-administered test is recommended for individuals aged 15 years and older. Adult-collection is required for testing children 2-14 years old.

DETECT CURRENT AND NEW COVID VARIANTS
iHealth has completed in-lab testing on several heat inactivated variant strains and the results show that iHealth COVID-19 Antigen Rapid Test was able to detect the mutations.

GROUP TESTING MANAGING VIA MOBILE APP
The iHealth COVID-19 Test app allows the administrator of a small group to monitor and track the group members’ test results when needed at school, work or event.

This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 15 years or older with symptoms of COVID-19 within the first 7 days of symptom onset. This test is also authorized for non-prescription home use with adult-collected nasal swab samples from individuals aged 2 years or older with symptoms of COVID-19 within the first 7 days of symptom Onset.